ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

CAI and ValGenesis Partner to Deliver AI-Enabled Digital Validation for the Life Sciences Industry

INDIANAPOLIS, Ind.—August 25, 2025 — CAI, a global professional services firm specializing in operational readiness for regulated industries, today announced a strategic partnership with ValGenesis, Inc., a leader in digital validation lifecycle management. Together, the companies will help life sciences organizations modernize validation processes and improve compliance through the power of artificial intelligence.

As part of the partnership, CAI will provide expert implementation services for the ValGenesis Smart GxP™ Platform, enabling clients to transition from manual, paper-based validation to a digital, data-driven approach. This integration supports more agile tech transfer, greater process consistency, and improved regulatory responsiveness across product lifecycles.

“Digital validation is essential to staying competitive in today’s life sciences landscape,” said Sheena Dempsey, CEO of CAI. “This partnership with ValGenesis allows us to help clients transform regulatory requirements into opportunities for faster, smarter delivery. By combining our on-the-ground expertise with AI-enabled tools, we’re accelerating innovation and improving patient access to life-changing therapies.”

The ValGenesis Smart GxP™ Platform unifies validation and process development into a single, scalable system. By digitally connecting all stages of the product lifecycle, it enables a closed-loop feedback cycle from development through commercial manufacturing—reducing risk while enhancing speed and traceability.

“ValGenesis is enabling faster market entry for vital therapies by transforming how life sciences companies approach validation,” said Bo Olsen, SVP of Partners at ValGenesis. “By partnering with CAI, we're ensuring that customers benefit not just from advanced technology, but from the expert services needed to implement and scale it successfully."

This collaboration reflects CAI’s commitment to delivering digital solutions that are grounded in real-world execution. With a legacy of success in regulated environments and a team of experienced practitioners, CAI supports organizations in adopting new technologies that improve performance, ensure compliance, and deliver better outcomes for patients.

 

About CAI

CAI is a global professional services firm focused on operational readiness, compliance, and performance in Life Sciences and Mission Critical industries. Since 1996, CAI has helped bring life-changing products to market by combining deep technical expertise with hands-on project delivery. The company is 100% employee-owned and actively contributes to industry standards through organizations including ISPE, ASHRAE, ASTM, and BCA. Learn more at https://caiready.com.

About ValGenesis Inc.

ValGenesis is the creator of Smart GxP™, the life sciences industry’s first fully integrated, cloud-based, AI-enabled platform for end-to-end product lifecycle digitalization. Trusted by 30 of the world’s top 50 life sciences companies, ValGenesis helps organizations accelerate development, streamline operations, and meet compliance goals with confidence. Learn more at https://www.valgenesis.com.

Media Contact:

LifeSciences@caiready.com | +1 317-271-6082

Technical Contact:

Jonathon Thompson, Director of Digital Products, CAI | jonathon.thompson@cagents.com 

 

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.